1. Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort study†. (16th May 2014) Authors: Grothey, Axel; Flick, E. Dawn; Cohn, Allen L.; Bekaii‐Saab, Tanios S.; Bendell, Johanna C.; Kozloff, Mark; Roach, Nancy; Mun, Yong; Fish, Susan; Hurwitz, Herbert I. Journal: Pharmacoepidemiology and drug safety Issue: Volume 23:Number 7(2014:Jul.) Page Start: 726 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of concomitant dosing with acid-reducing agents and vemurafenib dose on survival in patients with BRAFV600 mutation–positive metastatic melanoma treated with vemurafenib ± cobimetinib. (July 2019) Authors: Lewis, Karl; Hauschild, Axel; Larkin, James; Ribas, Antoni; Flaherty, Keith T.; McArthur, Grant A.; Dréno, Brigitte; McKenna, Edward; Zhu, Qian; Mun, Yong; Ascierto, Paolo A. Journal: European journal of cancer Issue: Volume 116(2019) Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Phase 2, multicenter GIBB study of obinutuzumab plus bendamustine in previously untreated patients with chronic lymphocytic leukemia. Issue 4 (21st March 2021) Authors: Sharman, Jeff P.; Burke, John M.; Yimer, Habte A.; Boxer, Michael A.; Babu, Sunil; Li, Jia; Mun, Yong; Danilov, Alexey V. Journal: Leukemia & lymphoma Issue: Volume 62:Issue 4(2021) Page Start: 791 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations. Issue 7 (July 2019) Authors: Soumerai, Jacob D; Ni, Ai; Darif, Mohamed; Londhe, Anil; Xing, Guan; Mun, Yong; Kay, Neil E; Shanafelt, Tait D; Rabe, Kari G; Byrd, John C; Chanan-Khan, Asher A; Furman, Richard R; Hillmen, Peter; Jones, Jeffrey; Seymour, John F; Sharman, Jeffrey P; Ferrante, Lucille; Mobasher, Mehrdad; Stark, Th... Journal: Lancet Issue: Volume 6:Issue 7(2019) Page Start: e366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study. Issue 4 (April 2022) Authors: Casulo, Carla; Larson, Melissa C; Lunde, Julianne J; Habermann, Thomas M; Lossos, Izidore S; Wang, Yucai; Nastoupil, Loretta J; Strouse, Christopher; Chihara, Dai; Martin, Peter; Cohen, Jonathon B; Kahl, Brad S; Burack, W Richard; Koff, Jean L; Mun, Yong; Masaquel, Anthony; Wu, Mei; Wei, Michael ... Journal: Lancet Issue: Volume 9:Issue 4(2022) Page Start: e289 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Utility of measurable residual disease for predicting treatment outcomes with BCR- and BCL2-Targeted therapies in patients with CLL. Issue 12 (15th October 2022) Authors: Wierda, William G.; Kipps, Thomas J.; Al-Sawaf, Othman; Chyla, Brenda; Biondo, Juliana M. L.; Mun, Yong; Jiang, Yanwen; Seymour, John F. Journal: Leukemia & lymphoma Issue: Volume 63:Issue 12(2022) Page Start: 2765 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Vemurafenib treatment for patients with locally advanced, unresectable stage IIIC or metastatic melanoma and activating exon 15 BRAF mutations other than V600E. Issue 6 (December 2017) Authors: Hallmeyer, Sigrun; Gonzalez, Rene; Lawson, David H.; Cranmer, Lee D.; Linette, Gerald P.; Puzanov, Igor; Taback, Bret; Cowey, C. Lance; Ribas, Antoni; Daniels, Gregory A.; Moore, Timothy; Gibney, Geoffrey T.; Tawbi, Hussein; Whitman, Eric; Lee, Geraldine; Mun, Yong; Liu, Shiyao; Hamid, Omid Journal: Melanoma research Issue: Volume 27:Issue 6(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗